ArticleDiseases (Basel, Switzerland)2025

Targeting Soluble Amyloid Oligomers in Alzheimer's Disease: A Hypothetical Model Study Comparing Intrathecal Pseudodelivery of mAbs Against Intravenous Administration.

Manuel Menendez-GonzalezPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.